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Background
Cardiac involvement is common in different forms of
amyloidosis and associated with limited survival. We
aimed to use gadolinium (GAD) contrast-enhanced car-
diac magnetic resonance imaging (CE-CMR) to charac-
terize CE-CMR patterns that are related to the different
forms of amyloidosis.
Methods
In total, 115 patients (70 male, 45 female; mean age 60.7
±1.2 years) with different forms of amyloidosis (AL n=
63, TTR n=52) were evaluated by evaluated by Vector-
ECG gated 1.5T whole-body CMR (Achieva Intera® Phi-
lips Medical Systems, Best, the Netherlands) and
included SSFP and CE-CMR 2-,3-,4-chamber and short-
axis planes. EDV, ESV, EF and myocardial mass were
analyzed on a standard workstation. Longitudinal func-
tion was assessed by mitral (MAPSE) and tricuspid
(TAPSE) annular plane systolic excursion. CE-CMR pat-
terns were analyzed qualitatively (subepicardial, suben-
docardial, patchy) and semi-quantitatively (absent = 0,
weak = 1, moderate = 2, severe = 3) in a modified 16
segment AHA model (maximal sum 48) of the left ven-
tricle. Univariate and multivariate analysis were per-
formed to define predictors of survival.
Results
Patients with TTR amyloidosis were significantly older
and had lower TAPSE (14.6±0.9 mm vs. 17.3±0.9 mm;
p<0.05) as compared to patients with AL. Both cohorts
did not differ in LV mass, LV ejection fraction, and
MAPSE. CE-CMR was observed in 107 (93%) of the
patients (AL n=59, 93.7%; TTR n=48, 92.3%). There was
no difference between both forms of amyloidosis con-
cerning sum of CE-CMR in the 16 segments by semi-
quantitative analysis (AL 25.8±2.2; TTR 28.6±2.2).
In each of the 16 LV segments more severe CE-CMR
was associated with an increase of LV mass as well as a
decrease of LV ejection fraction, MAPSE and TAPSE,
respectively (p<0.001). In TTR patients a more intensive
CE-CMR was found in the subepicardial layer of the
basal anterolateral (p<0.001), inferolateral (p<0.001) and
of the midventricular inferolateral segment (p<0.001) as
compared to AL patients.
During mean survival of 34.2±2.4 months there were
49 fatal events (death n=33; heart transplant n=16). Sur-
vival of AL patients was significantly worse as compared
to TTR patients (p<0.05; logrank 6.225). In AL patients
presence of subepicardial, subendocardial and patchy
CE-CMR, LV mass, MAPSE, and TAPSE, but not LV
ejection fraction, CE-CMR of LA, RA, RV or interatrial
septum were predictors of survival by univariate analy-
sis. By multivariate analysis subendocardial and patchy
CE-CMR as well as LV mass were independent predic-
tors of survival.
Conclusions
Prevalence of CE-CMR is high and appears to be asso-
ciated with the severity of cardiac dysfunction in differ-
ent forms of cardiac amyloidosis. Survival of patients
with AL amyloidosis was worse as compared to TTR
amyloidosis. Besides LV mass subendocardial and patchy
CE-CMR were independent predictors of survival in
patients with AL amyloidosis.
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